Peoples Bancorp of North Carolina posts $5.2M Q2 earnings
Peoples Bancorp of North Carolina (NASDAQ:PEBK) reported second-quarter 2026 net earnings of $5.2 million, or $0.98 per basic share and $0.96 per diluted share.
Peoples Bancorp of North Carolina (NASDAQ:PEBK) reported second-quarter 2026 net earnings of $5.2 million, or $0.98 per basic share and $0.96 per diluted share.
U.S. stock futures climbed Monday as oil prices declined after Iran signaled it remained open to negotiations following nine days of U.S. strikes.
Gregory Daco, chief economist at EY-Parthenon, says he thinks the Federal Reserve won't move on interests rates for the rest of this year. Daco talks about what he wants to see from the new Chairman Kevin Warsh. Daco speaks on "Bloomberg Surveillance."
AMC Entertainment Holdings (NYSE:AMC) reported second-quarter revenue of $1.5967 billion, an increase of 14.2% from $1.3979 billion a year earlier.
MainStreet Bancshares (NASDAQ:MNSB) reported second-quarter 2026 net income of $4.7 million, driven by disciplined expense management and steady loan growth.
Destination XL Group (NASDAQ:DXLG) filed a preliminary proxy statement with the SEC regarding its pending merger agreement with FBB Holdings I, also known as FullBeauty.
Dynex Capital (NYSE:DX) reported second-quarter economic return of $0.81 per common share and book value of $12.90 per share as of June 30, 2026.
The CEO of Dubai airports said operations are normal and they're operating at nearly full capacity, despite the recent escalation of the conflict in the Middle East. Paul Griffiths spoke with Bloomberg's Guy Johnson from the Farnborough air show.
Andy Burnham delivered his first speech since becoming the new UK prime minister, pledging to end the nation's political instability with a new economic model. Burnham spoke outside No. 10 Downing Street after being invited by King Charles III to form a new government.
Halozyme Therapeutics (NASDAQ:HALO) announced a global collaboration and license agreement with Incyte (NASDAQ:INCY) to develop subcutaneous formulations of INCA033989.
Nuvation Bio (NYSE:NUVB) reported updated long-term Phase 2 data for safusidenib in chemotherapy- and radiotherapy-naïve grade 2 IDH1-mutant glioma.
The US conducted a ninth straight day of airstrikes on Iran, bombing military targets and communications networks trying to force the Islamic Republic to stop shipping attacks and reopen the Strait of Hormuz. Iran continued to attack US bases in the likes of Kuwait, Jordan, Bahrain and Iraq. Tyler Kendall reports on Bloomberg Television.